DrugPatentWatch Database Preview
Gw Res Ltd Company Profile
What is the competitive landscape for GW RES LTD, and when can generic versions of GW RES LTD drugs launch?
GW RES LTD has one approved drug.
There are nine US patents protecting GW RES LTD drugs.
There are fifty patent family members on GW RES LTD drugs in fifteen countries.
Summary for Gw Res Ltd
| International Patents: | 50 |
| US Patents: | 9 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Gw Res Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gw Res Ltd | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | 9,956,183 | Start Trial | Start Trial | ||||
| Gw Res Ltd | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | 9,956,186 | Start Trial | Start Trial | ||||
| Gw Res Ltd | EPIDIOLEX | cannabidiol | SOLUTION;ORAL | 210365-001 | Sep 28, 2018 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Gw Res Ltd Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | 2016016459 | Start Trial |
| United Kingdom | 2531093 | Start Trial |
| United Kingdom | 201418171 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
